These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27312006)

  • 1. Generation and characterization of CD1d-specific single-domain antibodies with distinct functional features.
    Lameris R; de Bruin RC; van Bergen En Henegouwen PM; Verheul HM; Zweegman S; de Gruijl TD; van der Vliet HJ
    Immunology; 2016 Sep; 149(1):111-21. PubMed ID: 27312006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting the CD1d-iNKT cell axis for potentiation of DC-based cancer vaccines.
    Lameris R; Schneiders FL; de Gruijl TD; van der Vliet HJ
    Methods Mol Biol; 2014; 1139():155-65. PubMed ID: 24619678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction.
    Gentilini MV; Pérez ME; Fernández PM; Fainboim L; Arana E
    Cancer Immunol Immunother; 2016 May; 65(5):551-62. PubMed ID: 26969612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD1d-dependent endogenous and exogenous lipid antigen presentation.
    McEwen-Smith RM; Salio M; Cerundolo V
    Curr Opin Immunol; 2015 Jun; 34():116-25. PubMed ID: 25805574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing the antitumor functions of invariant natural killer T cells using a soluble CD1d-CD19 fusion protein.
    Das R; Guan P; Wiener SJ; Patel NP; Gohl TG; Evans E; Zauderer M; Nichols KE
    Blood Adv; 2019 Mar; 3(5):813-824. PubMed ID: 30858151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human dendritic cells derived from embryonic stem cells stably modified with CD1d efficiently stimulate antitumor invariant natural killer T cell response.
    Zeng J; Wang S
    Stem Cells Transl Med; 2014 Jan; 3(1):69-80. PubMed ID: 24292792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
    Gerth E; Mattner J
    Front Immunol; 2019; 10():1449. PubMed ID: 31293596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Navigating the Role of CD1d/Invariant Natural Killer T-cell/Glycolipid Immune Axis in Multiple Myeloma Evolution: Therapeutic Implications.
    Papoutselis M; Spanoudakis E
    Clin Lymphoma Myeloma Leuk; 2020 Jun; 20(6):358-365. PubMed ID: 32234294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Function and expression of CD1d and invariant natural killer T-cell receptor in the cotton rat (Sigmodon hispidus).
    Fichtner AS; Paletta D; Starick L; Schumann RF; Niewiesk S; Herrmann T
    Immunology; 2015 Dec; 146(4):618-29. PubMed ID: 26346465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.
    Lawson V
    Immunology; 2012 Sep; 137(1):20-7. PubMed ID: 22734667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy.
    Weinkove R; Brooks CR; Carter JM; Hermans IF; Ronchese F
    Haematologica; 2013 Mar; 98(3):376-84. PubMed ID: 23065503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells.
    Schütze K; Petry K; Hambach J; Schuster N; Fumey W; Schriewer L; Röckendorf J; Menzel S; Albrecht B; Haag F; Stortelers C; Bannas P; Koch-Nolte F
    Front Immunol; 2018; 9():2553. PubMed ID: 30524421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells.
    Bosma A; Abdel-Gadir A; Isenberg DA; Jury EC; Mauri C
    Immunity; 2012 Mar; 36(3):477-90. PubMed ID: 22406267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophospholipid presentation by CD1d and recognition by a human Natural Killer T-cell receptor.
    López-Sagaseta J; Sibener LV; Kung JE; Gumperz J; Adams EJ
    EMBO J; 2012 Apr; 31(8):2047-59. PubMed ID: 22395072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of NKT14m and Low Dose IL-12 Promotes Invariant Natural Killer T Cell IFN-γ Production and Tumor Control.
    Guan P; Schaub R; Nichols KE; Das R
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d.
    Clark K; Yau J; Bloom A; Wang J; Venzon DJ; Suzuki M; Pasquet L; Compton BJ; Cardell SL; Porcelli SA; Painter GF; Zajonc DM; Berzofsky JA; Terabe M
    Front Immunol; 2019; 10():2355. PubMed ID: 31649670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
    Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
    Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role for invariant chain in CD1d-mediated selection and maturation of Vα14-invariant NKT cells.
    Sillé FC; Martin C; Jayaraman P; Rothchild A; Besra GS; Behar SM; Boes M
    Immunol Lett; 2011 Sep; 139(1-2):33-41. PubMed ID: 21565221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoactivable Glycolipid Antigens Generate Stable Conjugates with CD1d for Invariant Natural Killer T Cell Activation.
    Veerapen N; Kharkwal SS; Jervis P; Bhowruth V; Besra AK; North SJ; Haslam SM; Dell A; Hobrath J; Quaid PJ; Moynihan PJ; Cox LR; Kharkwal H; Zauderer M; Besra GS; Porcelli SA
    Bioconjug Chem; 2018 Sep; 29(9):3161-3173. PubMed ID: 30085659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the recognition of C20:2-αGalCer by the invariant natural killer T cell receptor-like antibody L363.
    Yu ED; Girardi E; Wang J; Mac TT; Yu KO; Van Calenbergh S; Porcelli SA; Zajonc DM
    J Biol Chem; 2012 Jan; 287(2):1269-78. PubMed ID: 22110136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.